Given the frequency with which bipolar disorder relapses occur, the perinatal period may be a precarious time for mother and baby.1 In an effort to reconcile differences among different bipolar disorder guidelines, Graham and colleagues sought to decipher the recommendations on bipolar disorder in the perinatal period by reviewing 11 international guidelines published from 2005 to 2015.
Probiotics lowered the rate of rehospitalization after a manic episode, according to a small controlled trial released this month. This marks the first clinical trial of probiotics in bipolar disorder, and it builds on previous research that has found promise for these “healthy bacteria” in depression, anxiety, cognition, and autism.
Early intervention in bipolar disorder (BPD) is “gaining momentum” as a way of averting potentially irreversible harm from the disease, as the early phases may be more responsive than later stages to treatments and may also require less aggressive therapies.
A new Swedish study published in the Journal of the American Medical Association finds that lithium remains the gold standard for helping individuals with bipolar disorder avoid hospitalization. The new study investigated the long-term effects of different drugs for bipolar disorder.
Millions of Americans who suffer from bipolar disorder depend on lithium. The medication has been prescribed for half a century to help stabilize patients’ moods and prevent manic or depressive episodes. Yet what it does in the brain—and why it does not work for some people—has remained largely mysterious.
Bipolar Disorder (BD) is a multifactorial brain disorder in which patients experience radical shifts in mood and undergo periods of depression followed by periods of mania. It has been known for some time that both environmental and genetic factors play important roles in the disease. For instance, being exposed to high levels of stress for long periods, and especially during childhood, has been associated with the development of BD.
Immediate early genes (IEGs) are a class of genes that respond very rapidly to environmental stimuli, and that includes stress. IEGs respond to a stressor by activating other genes that lead to neuronal plasticity, the ability of brain cells to change in form and function in response to changes in the environment. Ultimately, it is the process of neuronal plasticity that gives the brain the ability to learn from and adapt to new experiences.
Long-term study in more than 1,100 people yields a new seven-factor framework that could help patients, clinicians and researchers
Newswise — ANN ARBOR, Mich. – Nearly 6 million Americans have bipolar disorder, and most have probably wondered why. After more than a decade of studying over 1,100 of them in-depth, a University of Michigan team has an answer – or rather, seven answers.
In fact, they say, no one genetic change, or chemical imbalance, or life event, lies at the heart of every case of the mental health condition once known as manic depression.
People with high IQ are considered to have an advantage in many domains. They are predicted to have higher educational attainment, better jobs, and a higher income level. Yet, it turns out that a high IQ is also associated with various mental and immunological diseases like depression, bipolar disorder, anxiety, ADHD as well as allergies, asthma, and immune disorders. Why is that? A new paper published in the journal Intelligence reviews the literature and explores the mechanisms that possibly underlie this connection.
Can orange light therapy help people who have serious mental disorders? Who hear voices and see things that aren’t there? Or who are thinking about committing suicide?
“Emergency psychiatric care hasn’t seen much new thinking about approaches to treatment. We’re trying to do something about that,” says Håvard Kallestad, a researcher at the Norwegian University of Science and Technology’s (NTNU) Department of Mental Health. He is part of a team that is integrating a special light treatment into the new emergency psychiatric center at St. Olavs Hospital in Trondheim.
A groundbreaking Loyola Medicine study suggests that a simple 15-minute electrocardiogram could help a physician determine whether a patient has major depression or bipolar disorder.